Clinical Trial Update: Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology [Phase 3]

View source ↗

Summary

A Phase 3 pharmacokinetics and safety study of Alfuzosin in children and adolescents with neurogenic bladder due to neuropathic etiology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Urinary Bladder Neurogenic | Phase 3 | Status: COMPLETED